Literature DB >> 21851203

A comparison of cognitive function in patients under maintenance treatment with heroin, methadone, or buprenorphine and healthy controls: an open pilot study.

Michael Soyka1, Claudia Limmer, Robert Lehnert, Gabriele Koller, Gabriele Martin, Heinrich Küfner, S Kagerer, Annina Haberthür.   

Abstract

INTRODUCTION: Cognitive impairment has been reported in drug-dependent patients under opioid maintenance treatment.
OBJECTIVES: To compare cognitive functioning in healthy controls and in opioid-dependent patients treated with Buprenorphine, Heroin, or methadone maintenance.
METHODS: We used the standardized test battery ART-90 to study cognitive function in patients under long-term heroin treatment (n = 20), Bup (n = 22), or Met (n = 24) maintenance treatment and healthy controls (n = 25).
RESULTS: Patients receiving heroin performed significantly worse than healthy controls in most domains. Heroin patients performed worse than patients in the other two treatment groups in subtests measuring psychomotor performance under stress conditions and monotony. CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: Although a number of limitations must be taken into account, this study provides some preliminary evidence that cognitive function may be more impaired in patients under heroin maintenance treatment than in patients receiving Bup or Met and in healthy controls.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21851203     DOI: 10.3109/00952990.2011.600381

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  12 in total

1.  Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment.

Authors:  Saurabh Gupta; Jennifer E Iudicello; Chuan Shi; Scott Letendre; Adam Knight; Jianhua Li; Patricia K Riggs; Donald R Franklin; Nichole Duarte; Hua Jin; J Hampton Atkinson; Xin Yu; Zunyou Wu; Igor Grant; Robert K Heaton
Journal:  Drug Alcohol Depend       Date:  2014-01-13       Impact factor: 4.492

Review 2.  The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.

Authors:  Vanessa Chilunda; Tina M Calderon; Pablo Martinez-Aguado; Joan W Berman
Journal:  Brain Res       Date:  2019-08-29       Impact factor: 3.252

3.  [Driving ability with alcohol and drug dependence and schizophrenia].

Authors:  M Soyka; S Dittert; S Kagerer-Volk; M Soyka
Journal:  Nervenarzt       Date:  2014-07       Impact factor: 1.214

Review 4.  Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.

Authors:  Matias Jaureguiberry-Bravo; Rebecca Wilson; Loreto Carvallo; Joan W Berman
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

5.  Putative mechanisms of cognitive decline with implications for clinical research and practice.

Authors:  Tadeu Oliveira; Angela Starkweather; Divya Ramesh; Joseph Fetta; Debra Lynch Kelly; Debra E Lyon; Lana Sargent
Journal:  Nurs Forum       Date:  2018-01-18

Review 6.  Effect of Opioid Use on Immune Activation and HIV Persistence on ART.

Authors:  Livio Azzoni; David Metzger; Luis J Montaner
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-25       Impact factor: 7.285

7.  Low-dose add-on memantine treatment may improve cognitive performance and self-reported health conditions in opioid-dependent patients undergoing methadone-maintenance-therapy.

Authors:  Yun-Hsuan Chang; Shiou-Lan Chen; Sheng-Yu Lee; Po See Chen; Tzu-Yun Wang; I Hui Lee; Kao Chin Chen; Yen Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  Sci Rep       Date:  2015-05-19       Impact factor: 4.379

8.  Driving and legal status of Spanish opioid-dependent patients.

Authors:  Carlos Roncero; F Javier Álvarez; Carmen Barral; Susana Gómez-Baeza; Begoña Gonzalvo; Laia Rodríguez-Cintas; M Teresa Brugal; Carlos Jacas; Anna Romaguera; Miguel Casas
Journal:  Subst Abuse Treat Prev Policy       Date:  2013-06-03

9.  Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study.

Authors:  Pekka Rapeli; Carola Fabritius; Hely Kalska; Hannu Alho
Journal:  Subst Abuse Treat Prev Policy       Date:  2012-11-02

10.  Cognitive control in opioid dependence and methadone maintenance treatment.

Authors:  Ding-Lieh Liao; Cheng-Yi Huang; Sien Hu; Su-Chen Fang; Chi-Shin Wu; Wei-Ti Chen; Tony Szu-Hsien Lee; Pau-Chung Chen; Chiang-Shan R Li
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.